The level and activity of critical regulatory proteins in cells are tightly controlled by several tiers of post-translational modifications. HIF-1 is maintained at low levels under normoxia conditions by the collaboration between PHD proteins and the VHL-containing E3 ubiquitin ligase complex. We recently identified a new physiologically relevant mechanism that regulates HIF-1 stability in the nucleus in response to cellular oxygen levels. This mechanism is based on the collaboration between the SET7/9 methyltransferase and the LSD1 demethylase. SET7/9 adds a methyl group to HIF-1, which triggers degradation of the protein by the ubiquitin-proteasome system, whereas LSD1 removes the methyl group, leading to stabilization of HIF-1 under hypoxia conditions. In cells from knock-in mice with a mutation preventing HIF-1 methylation (Hif1 KA/KA ), HIF-1 levels were increased in both normoxic and hypoxic conditions. Hif1 KA/KA knock-in mice displayed increased hematological parameters, such as red blood cell count and hemoglobin concentration. They also displayed pathological phenotypes; retinal and tumor-associated angiogenesis as well as tumor growth were increased in Hif1 Hypoxia-inducible factor-1 (HIF-1) is a key transcriptional regulator responsible for the adaptation of cells and tissues to a state of low oxygen (hypoxia). Since uncontrolled expression of hypoxia-inducible genes is harmful to normal physiology, the cellular level of HIF-1 is tightly regulated, primarily by ubiquitin-mediated degradation. In the presence of physiological concentrations of oxygen (normoxia), HIF-1 is hydroxylated on proline residues by proline hydroxylase domain (PHD) proteins (PHD1/PHD2/PHD3). Hydroxylated proline residues serve as a marker for recognition by the VHL-containing CUL2 E3 ubiquitin ligase complex. On the other hand, the lack of oxygen in hypoxia triggers reduced hydroxylation and increased stability of HIF-1, which leads to its translocation to the nucleus, where it heterodimerizes with HIF-1 and induces the expression of target genes. In addition to controlling HIF-1 transcriptional activity by regulating HIF-1 stability, other means of regulation include SUMOylaton, acetylation, and phosphorylation.
Recently, we identified another control mechanism of HIF-1 stability (Fig. 1 ). We will discuss the following three aspects of this new discovery: molecular mechanisms, physiological significance as revealed by a Hif1 KA/KA knock-in mouse model, and clinical relevance to human cancers. In general, the cellular level of HIF-1 is very low in normoxic conditions. In the presence of MG132, a proteasome inhibitor, we were able to identify methylation of HIF-1 on the 32nd lysine residue, and found that this methylation is mediated by SET7/9 methyltransferase in the nucleus. Interestingly, the level of HIF-1 methylation in the presence of MG132, which was measured by a HIF-1 methylation-specific antibody, is high in normoxia, decreases upon initiation of hypoxia, and increases again after longer exposure to hypoxia. This inversely correlates with the protein level of HIF-1 without proteasome inhibitor treatment. HIF-1 methylation could be a signal for poly-ubiquitination by an unidentified E3 ligase that results in the degradation of HIF-1, which is independent of the cytosolic destabilization mechanism of HIF-1. We sought to identify the underlying mechanism controlling the stabilization of HIF-1 from early to later periods of hypoxia. On the basis of decreased methylation of HIF-1, we found that a demethylating enzyme, LSD1, removes a methyl group from HIF-1 to stabilize it. The HIF-1 protein level under hypoxia was higher in Lsd1-deficient mouse embryonic fibroblasts (MEFs) compared to control MEFs. Therefore, SET7/9 and LSD1 are newly identified regulators of hypoxia that control Perspective http://bmbreports.org Fig. 1 . Schematic model of regulation of HIF-1 protein stability. Under normoxic conditions, HIF-1 protein stability is regulated by PHD-dependent hydroxylation in the cytoplasm. Hydroxylated HIF-1 is degraded by 26S proteasomes to maintain low HIF-1 protein levels. In contrast, SET7/9-dependent methylation and LSD1-dependent demethylation of HIF-1 regulate protein stability primarily in the nucleus in a hydroxylation-independent manner during normoxia. Upon hypoxia, HIF-1 is stabilized by LSD1-dependent demethylation in the nucleus.
HIF-1 stability.
The physiological relevance of this new mechanism was evaluated with a Hif1 KA/KA knock-in mouse model, in which HIF-1 resists methylation. These mice are largely indistinguishable from their wild-type counterparts in growth, fertility, and life-span. HIF-1 levels are slightly higher in several tissues from Hif1 KA/KA mice compared to those from wild-type mice; the difference becomes more prominent after treating the mice with a prolyl hydroxylase inhibitor, dimethyloxalylglycine (DMOG), which protects HIF-1 from cytosolic degradation. This phenomenon can be explained as follows: HIF-1 that resists degradation in the cytosol is normally degraded in the nucleus by SET7/9-mediated methylation followed by ubiquitination and proteasomal degradation. However, methylation-defective HIF-1 accumulates in the nucleus after resisting degradation in the cytosol. Along with higher levels of HIF-1 protein, Hif1 KA/KA mice display increased hematocrit, red blood cell count, and hemoglobin levels. One well-known function of HIF-1 is to promote angiogenesis by activating the transcription of angiogenic factors. Two types of angiogenesis, retinal and tumor-associated, were both significantly elevated in Hif1 KA/KA mice along with increased expression of VEGF in both cases. Although the phenotype was not prominent under normal physiological conditions, Hif1 KA/KA mice showed clear alterations in the methylation-derived clearance system in pathological situations.
Another intriguing characteristic of Hif1
KA/KA cells and mice is an increased tendency for tumorigenesis. MEFs derived from Hif1 KA/KA mice showed enhanced cell migration as well as colony formation. MDA-MB231 breast cancer cells that stably express methylation-resistant HIF-1 K32A protein form more and larger tumors in athymic nude mice compared to cells expressing wild-type HIF-1. In order to determine if this newly found mechanism has any relevance to human cancer, we searched databases for HIF-1 mutations in human cancers and identified two frequently occurring mutations, S28Y and R30Q. Both are situated near the methylation site at K32; however, a mutation in K32 itself was not detected. Both S28Y and R30Q mutant HIF-1 proteins are resistant to methylationdependent degradation and cells expressing the mutant HIF-1 exhibit increased migration. Although this hypothesis requires systemic validation, it is highly possible that these HIF-1 mutations contribute to the development and/or progression of human cancers.
